SEC Form 4 · accession 0001791742-26-000002
Instil Bio, Inc. · TIL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gwendolyn Binder
Director
Period of report
Jun 11, 2026
Accepted (ET)
Jun 12, 2026 · 2:37 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001789769
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $7.93 | Jun 11, 2026 | A | 6,500 | A | — | Jun 10, 2036 | Common Stock | 6,500 | 6,500 | D |
Explanation of responses
- F1The option will vest in 12 substantially equal monthly installments commencing on July 11, 2026, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the "Plan") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan).